SyntekaBio, Inc. (KOSDAQ:226330)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,130.00
-112.00 (-9.02%)
At close: Aug 24, 2026

SyntekaBio Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-13,577-17,378-7,213-11,398-4,506-14,803
Depreciation & Amortization
1,9852,0232,2541,7621,4731,158
Loss (Gain) From Sale of Assets
25.2725.275.73--0.13-
Asset Writedown & Restructuring Costs
24.2746.911.267220.25-
Stock-Based Compensation
574.72625572.84779.78793.17364.78
Provision & Write-off of Bad Debts
------0.27
Other Operating Activities
1,9576,132-5,977778.98-5,8136,984
Change in Accounts Receivable
-675.12-847.590.060.8353.97-32.15
Change in Unearned Revenue
-----171.11-
Change in Other Net Operating Assets
-680.49-1,277-152.95-73.97-360.5288.52
Operating Cash Flow
-10,366-10,650-10,509-8,078-8,511-6,040
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-176.08-11.01-5,707-9,364-8,389-7,479
Sale of Property, Plant & Equipment
1414--0.13-
Sale (Purchase) of Intangibles
-58.28-56.51-109.79-65.61-368.06-69.14
Investment in Securities
----39,000-560
Other Investing Activities
77.3376.2820-0-9.964.52
Investing Cash Flow
-143.0322.76-5,797-9,43030,233-8,104

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-14,107----
Long-Term Debt Issued
-18,48010,00010,000-25,000
Total Debt Issued
20,58732,58710,00010,000-25,000
Short-Term Debt Repaid
--14,107----
Long-Term Debt Repaid
--27,327-1,730-8,228-263.16-402
Total Debt Repaid
-32,019-41,434-1,730-8,228-263.16-402
Net Debt Issued (Repaid)
-11,431-8,8478,2701,772-263.1624,598
Issuance of Common Stock
23,76523,76526212174.13414.15
Other Financing Activities
-0-0-0-0-196.51
Financing Cash Flow
12,33414,9198,5321,784-89.0325,209

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.82-11.79171.548.83-0.08-6.44
Miscellaneous Cash Flow Adjustments
-0-0---
Net Cash Flow
1,8264,280-7,602-15,67421,63411,058

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-10,542-10,661-16,216-17,442-16,899-13,520
Free Cash Flow Growth
------
Free Cash Flow Margin
-353.44%-310.88%-13413.89%-14133.89%-6926.24%-4269.46%
Free Cash Flow Per Share
-591.27-684.32-1063.33-1218.35-1250.52-1004.13
Levered Free Cash Flow
-6,885-10,391-19,769-9,212-1,735-15,780
Unlevered Free Cash Flow
-5,196-8,615-18,514-8,977-952.52-15,621

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
846.13942.54----
Cash Income Tax Paid
--55.89-130.5642.7967.64-8.71
Change in Working Capital
-1,356-2,124-152.9-73.15-477.65256.37